5/14
08:01 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
Low
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
5/14
08:01 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
Low
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
5/14
08:01 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
Low
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
5/14
08:01 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
Low
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at Stephens. They set an "overweight" rating and a $8.00 price target on the stock.
5/14
06:04 am
elev
Rating for ELEV
Low
Report
Rating for ELEV
5/3
09:57 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Medium
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
5/3
09:57 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Medium
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
5/3
09:37 am
elev
Rating for ELEV
Medium
Report
Rating for ELEV
5/3
09:37 am
elev
Rating for ELEV
Medium
Report
Rating for ELEV
4/9
08:09 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.